Sonelokimab, Placebo is a sterile solution in a single use prefilled syringe (PFS) intended for subcutaneous administration clinical trials

A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of subcutaneous sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (M1095-HS-301)

This study is testing a new medicine, sonelokimab, for adults with moderate to severe hidradenitis suppurativa (HS). It compares sonelokimab to a dummy treatment (placebo) to see if it improves HS symptoms and is safe to use.